Sushil Kumar

Dr. Sushil Kumar


Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 October 2020 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
MMMohit Motiwale
Mohit Motiwale
NYNeetu Singh Yadav
Neetu Singh Yadav
SKSushil Kumar
Sushil Kumar
TKTushar Kushwaha
Tushar Kushwaha
GCGourav Choudhir
Gourav Choudhir
DSDr. Pradeep K. Singour
Dr. Pradeep K. Singour
SARS-CoV-2 is liable for the worldwide coronavirus disease (COVID-19) exigency. This pandemic created the need for all viable treatment strategies available in the market. In this scenario, computer-aided drug design techniques can be efficiently applied for the quick identification of promising drug repurposing candidates. In the current study, we applied the molecular docking approach in conjugation with molecular dynamics (MD) simulations to find out potential inhibitors against Mpro of SARS-CoV-2 from previously reported SARS-3CL protease inhibitors. Our results showed that N-substituted isatin derivatives and pyrazolone compounds could be used as a potent inhibitor and may possess an anti-viral activity against SARS-CoV-2. However, further experimental investigation and validation of the selected hits are required to find out their suitability for clinical trials. Communicated by Ramaswamy H. Sarma


15 August 2013 in Journal of Applied Horticulture
Verified
Journal Article
Closed access
SCS.M. Chavan
S.M. Chavan
SKSushil Kumar
Sushil Kumar
SAS.S. Arve
S.S. Arve
Research papers on horticulture crops, biotechnology, tomato, apple, fruits vegetables, irrigation, water stress, drought resistance, postharvest technology etc

31 December 2024 in Journal of Genetic Engineering and Biotechnology
Verified
Journal Article
Open access
GCGourav Choudhir
Gourav Choudhir
SKSushil Kumar
Sushil Kumar
MSMohammad Shahid
Mohammad Shahid
Anas ShamsiAnas Shamsi
Anas Shamsi
Asimul IslamAsimul Islam
Asimul Islam
Cancer remains an awful challenge, despite years of targeting proteins to control its relentless growth and spread. Fungal metabolites, a treasure of natural chemicals, offer a glimmer of hope. Telomeres, the cellular “caps,” are a focal point in cancer research. This study explores the potential of stabilizing Telomeric Repeats-containing RNA G-quadruplex (TERRA G4) structures within telomeres. This stabilization could block telomerase, the enzyme that repairs telomeres, and potentially trigger cancer cell death. Agonodepsides A and B, two promising fungal metabolites, were chosen to investigate this exciting possibility. Agonodepside A and B were initially screened for drug likeness employing SwissAdme. AutoDock Vina was used for molecular docking, and ligands and TERRA G4 were prepared using PyRx and MGL tool. Discovery Studio software was utilized for the visualization of interactions between ligands and TERRA G4. For validation of docking results MD simulation for control and complexes was carried out for 250 ns and trajectories were analyzed for different parameters. MMPBSA was used to calculate binding free energy for control and complexes. To find the stable and lower energy states of complexes in comparison to control principal component analysis (PCA) and free energy landscape (FEL) were conducted. Absorption, distribution, metabolism, and excretion (ADME) of both agonodepsides followed Lipinski’s rule of five with zero violation. Molecular docking revealed several key interactions including hydrogen bonds, van der Waals interactions, π-alkyl and π-anion. MD simulation revealed that Agonodepside A interact with TERRA G4 and stabilize it while Agonodepside B interactions were transient. The MMPBSA binding free energy calculation, PCA and free energy landscapes supported the docking and MD simulation results. Lichenized fungi produce agonodepsides A and B, may fight cancer by targeting telomeres. Agonodepside A binds more strongly to telomeres than B, potentially blocking enzyme telomerase. Further studies are required to validate these findings and evaluate potential safety concerns.

6 August 2025 in South African Journal of Botany
Verified
Journal Article
Closed access
SSSakshi Sharma
Sakshi Sharma
GCGourav Choudhir
Gourav Choudhir
AIAsimul Islam
Asimul Islam
SKSushil Kumar
Sushil Kumar

26 November 2024 in In Silico Pharmacology
Verified
Journal Article
Closed access
PDF file
GCGourav Choudhir
Gourav Choudhir
SKSushil Kumar
Sushil Kumar
AKAnuj Kumar
Anuj Kumar